{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:35:37Z","timestamp":1791099337621,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,2,13]],"date-time":"2007-02-13T00:00:00Z","timestamp":1171324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,2,13]],"date-time":"2007-02-13T00:00:00Z","timestamp":1171324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1007\/s00213-007-0710-6","type":"journal-article","created":{"date-parts":[[2007,2,12]],"date-time":"2007-02-12T12:32:06Z","timestamp":1171283526000},"page":"159-170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents"],"prefix":"10.1007","volume":"192","author":[{"given":"Sharon","family":"Rosenzweig-Lipson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annmarie","family":"Sabb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Stack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irwin","family":"Lucki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E.","family":"Malberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Grauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Cryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey J.","family":"Sukoff Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Dunlop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Marquis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,2,13]]},"reference":[{"key":"710_CR1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/026988110201600403","volume":"16","author":"CE Beyer","year":"2002","unstructured":"Beyer CE, Boikess S, Luo B, Dawson LA (2002) Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study. J Psychopharmacol 16:297\u2013304","journal-title":"J Psychopharmacol"},{"key":"710_CR2","unstructured":"Bickerdike MJ, Adams DR, Bentley J, Benwell KR, Cliffe IA, Kennett GA, Knight AR, Malcolm CS, Misra A, Quirk K, Roffey JRA, Dourish CT (2002) Radioligand binding profile and in vitro functional efficacy of VER-3323, a novel 5-HT2C\/5-HT2B receptor agonist. 5th IUPHAR Satellite Meeting on Serotonin"},{"key":"710_CR3","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1021\/jm970030l","volume":"15","author":"M Bos","year":"1997","unstructured":"Bos M, Jenck F, Martin JR, Moreau JL, Sleight AJ, Wichmann J, Widmer U (1997) Novel agonists of 5HT2C receptors. Synthesis and biological evaluation of substituted 2-(indol-1-yl)-1-methylethylamines and 2-(indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved therapeutics for obsessive compulsive disorder. J Med Chem 15:2762\u20132769","journal-title":"J Med Chem"},{"key":"710_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0031-9384(03)00047-7","volume":"78","author":"JM Chou-Green","year":"2003","unstructured":"Chou-Green JM, Holscher TD, Dallman MF, Akana SF (2003) Compulsive behavior in the 5-HT2C receptor knockout mouse. Physiol Behav 78:641\u2013649","journal-title":"Physiol Behav"},{"key":"710_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0924-977X(01)00078-5","volume":"11","author":"F Clenet","year":"2001","unstructured":"Clenet F, De Vos A, Bourin M (2001) Involvement of 5-HT2C receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice. Eur Neuropsychopharmacol 11:145\u2013152","journal-title":"Eur Neuropsychopharmacol"},{"key":"710_CR6","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1038\/sj.npp.1300474","volume":"29","author":"TI Cremers","year":"2004","unstructured":"Cremers TI, Giorgetti M, Bosker FJ, Hogg S, Arnt J, Mork A, Honig G, Bogeso K-P, Westerink B, den Boer BHC, Wikstrom HV, Tecott LH (2004) Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade. Neuropsychopharmacology 29:1782\u20131789","journal-title":"Neuropsychopharmacology"},{"key":"710_CR7","first-page":"1120","volume":"295","author":"JF Cryan","year":"2000","unstructured":"Cryan JF, Lucki I (2000) Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine2C receptors. J Pharmacol Exp Ther 295:1120\u20131126","journal-title":"J Pharmacol Exp Ther"},{"key":"710_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0014-2999(98)00402-6","volume":"352","author":"JF Cryan","year":"1998","unstructured":"Cryan JF, McGrath C, Leonard BE, Norman TR (1998) Combining pindolol and paroxetine in an animal model of chronic antidepressant action\u2014can early onset of action be detected? Eur J Pharmacol 352:23\u201328","journal-title":"Eur J Pharmacol"},{"key":"710_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0091-3057(98)00245-7","volume":"63","author":"JF Cryan","year":"1999","unstructured":"Cryan JF, McGrath C, Leonard BE, Norman TR (1999) Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat. Pharmacol Biochem Behav 63:333\u2013338","journal-title":"Pharmacol Biochem Behav"},{"key":"710_CR10","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/sj.bjp.0703378","volume":"130","author":"LA Dawson","year":"2000","unstructured":"Dawson LA, Nguyen HQ, Smith DI, Schechter LE (2000) Effects of chronic fluoxetine treatment in the presence and absence of (\u00b1)pindolol: a microdialysis study. Br J Pharmacol 130:797\u2013804","journal-title":"Br J Pharmacol"},{"key":"710_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF02246053","volume":"119","author":"MJ Detke","year":"1995","unstructured":"Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 119:47\u201354","journal-title":"Psychopharmacology"},{"issue":"2","key":"710_CR12","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1124\/jpet.104.075382","volume":"313","author":"J Dunlop","year":"2005","unstructured":"Dunlop J, Sabb AL, Mazandarani H, Zhang J, Kalgaonker S, Shukhina E, Sukoff S, Vogel R, Stack G, Schechter L, Harrison BL, Rosenzweig-Lipson S (2005) WAY-163909 (7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]-diazepino[6,7,1hi]indole); A novel 5-HT2C receptor selective agonist with anorectic activity. J Pharmacol Exp Ther 313(2):862\u2013869","journal-title":"J Pharmacol Exp Ther"},{"key":"710_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1527-3458.2006.00167.x","volume":"12","author":"J Dunlop","year":"2006","unstructured":"Dunlop J, Marquis M, Kim HL, Leung L, Kao J, Cheesman C, Rosenzweig-Lipson S (2006) Pharmacological profile of the 5-HT2C receptor agonist WAY-163909 ((7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole); therapeutic potential in multiple indications. CNS Drug Review 12:167\u2013176","journal-title":"CNS Drug Review"},{"key":"710_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/BF02244962","volume":"107","author":"U Freo","year":"1992","unstructured":"Freo U, Holloway HW, Greig NH, Soncrant TT (1992) Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin. Psychopharmacology 107:30\u201338","journal-title":"Psychopharmacology"},{"key":"710_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0014-2999(98)00838-3","volume":"364","author":"A Harkin","year":"1999","unstructured":"Harkin A, Kelly JP, McNamara M, Connor TJ, Dredge K, Redmond A, Leonard BE (1999) Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression. Eur J Pharmacol 364:123\u2013132","journal-title":"Eur J Pharmacol"},{"key":"710_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.brainres.2004.03.032","volume":"1011","author":"A Hayashi","year":"2004","unstructured":"Hayashi A, Sonoda R, Kimura Y, Takasu T, Suzuki M, Sasamata M, Miyata K (2004) Antiobesity effect of YM348, a novel 5-HT2C receptor agonist in Zucker rats. Brain Res 1011:221\u2013227","journal-title":"Brain Res"},{"key":"710_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pbb.2003.09.020","volume":"77","author":"S Hogg","year":"2004","unstructured":"Hogg S, Dalvi A (2004) Acceleration of onset of action in schedule-induced polydipsia: combinations of SSRI and 5-HT1A and 5-HT1B receptor antagonists. Pharmacol Biochem Behav 77:69\u201375","journal-title":"Pharmacol Biochem Behav"},{"key":"710_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0163-7258(97)00004-1","volume":"74","author":"JP Kelly","year":"1997","unstructured":"Kelly JP, Wrynn AS, Leonard BE (1997) The olfactory bulbectomized rat as a model of depression: an update. Pharmacol Ther 74:299\u2013316","journal-title":"Pharmacol Ther"},{"key":"710_CR19","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/BF02245708","volume":"113","author":"AJ Kennedy","year":"1993","unstructured":"Kennedy AJ, Gibson EL, O\u2019Connell MT, Curzon G (1993) Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioural responses to mCPP. Psychopharmacology 113:262\u2013268","journal-title":"Psychopharmacology"},{"key":"710_CR20","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0028-3908(97)00038-5","volume":"36","author":"GA Kennett","year":"1997","unstructured":"Kennett GA, Wood, MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, Bromidge S, Forbes IT, Brown AM, Middlemiss DN, Blackburn TP (1997) SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 36:609\u2013620","journal-title":"Neuropharmacology"},{"key":"710_CR21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0028-3908(97)00038-5","volume":"36","author":"GA Kennett","year":"1998","unstructured":"Kennett GA, Trail B, Bright F (1998) Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B mediated. Neuropharmacology 36:609\u2013620","journal-title":"Neuropharmacology"},{"key":"710_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejphar.2003.10.004","volume":"283","author":"Y Kimura","year":"2004","unstructured":"Kimura Y, Hatanaka K, Naitou Y, Maeno K, Shimada I, Koakutsu A, Wanibuchi F, Yamaguchi T (2004) Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist. Eur J Pharmacol 283:37\u201343","journal-title":"Eur J Pharmacol"},{"key":"710_CR23","first-page":"49","volume-title":"Trends in drug research","author":"D Leyson","year":"1998","unstructured":"Leyson D, Kelder J (1998) Ligands for the 5-HT2C receptor as potential antidepressants and anxiolytics. In: van der Groot J (ed) Trends in drug research. Elsevier, Amsterdam, pp 49\u201361"},{"key":"710_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s002130000400","volume":"150","author":"A Mar","year":"2000","unstructured":"Mar A, Spreekmeester E, Rochford J (2000) Antidepressants preferentially enhance habituation to novelty in the olfactory bulbectomized rat. Psychopharmacology 150:52\u201360","journal-title":"Psychopharmacology"},{"key":"710_CR25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1124\/jpet.106.106989","volume":"320","author":"K Marquis","year":"2007","unstructured":"Marquis K, Sabb A, Logue SF, Stack G, Brennan JA, Piesla MJ, Comery TA, Grauer SM, Ashby CR, Nguyen HQ, Dawson LA, Stack G, Meltzer HY, Harrison BL, Rosenzweig-Lipson S (2007) WAY-163909 ((7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole): a novel 5-HT2C receptor selective agonist with preclinical antipsychotic-like activity. J Pharmacol Exp Ther 320:486\u2013496","journal-title":"J Pharmacol Exp Ther"},{"key":"710_CR26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0022-3565(24)37669-4","volume":"286","author":"JR Martin","year":"1998","unstructured":"Martin JR, Bos M, Jenck F, Moreau J, Mutel V, Sleight AJ, Wichmann J, Andrews JS, Berendsen HH, Broekkamp CL, Ruigt GS, Kohler C, Delft AM (1998) 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential. J Pharmacol Exp Ther 286:913\u2013924","journal-title":"J Pharmacol Exp Ther"},{"key":"710_CR27","first-page":"309.2","volume":"27","author":"RB McCall","year":"2001","unstructured":"McCall RB, Franklin SR, Hyslop DK, Knauer CS, Chio CL, Haber CL, Fitzgerald LW (2001) PNU-22394, a 5-HT2C receptor agonist, reduces feeding in rodents and produces weight loss in humans. Soc Neurosci Abstr 27:309.2","journal-title":"Soc Neurosci Abstr"},{"key":"710_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/026988119200600218","volume":"6","author":"PJ Mitchell","year":"1992","unstructured":"Mitchell PJ, Redfern PH (1992) Acute and chronic antidepressant drug treatments induce opposite effects in the social behaviour of rats. J Psychopharmacol 6:241\u2013257","journal-title":"J Psychopharmacol"},{"key":"710_CR29","first-page":"A32 (D2)","volume":"14","author":"PJ Mitchell","year":"2000","unstructured":"Mitchell PJ, Redfern PH (2000) Effects of m-chlorophenylpiperazine and mesulergine on rodent agonistic behaviour. J Psychopharmacol 14:A32 (PD2)","journal-title":"J Psychopharmacol"},{"key":"710_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/1381612053382250","volume":"11","author":"PJ Mitchell","year":"2005","unstructured":"Mitchell PJ, Redfern PH (2005) Animal models of depressive illness: the importance of chronic drug treatment. Curr Pharm Des 11:171\u2013203","journal-title":"Curr Pharm Des"},{"key":"710_CR31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/BF02246963","volume":"110","author":"JL Moreau","year":"1993","unstructured":"Moreau JL, Jenck F, Martin JR, Perrin S, Haefely WE (1993) Effects of repeated mild stress and two antidepressant treatments on the behavioral response to 5HT1C receptor activation in rats. Psychopharmacology 110:140\u2013144","journal-title":"Psychopharmacology"},{"key":"710_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0924-977X(96)00015-6","volume":"6","author":"J-L Moreau","year":"1996","unstructured":"Moreau J-L, Bos M, Jenck F, Martin JR, Mortas P, Wichmann J (1996) 5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats. Eur Neuropharmacol 6:169\u2013175","journal-title":"Eur Neuropharmacol"},{"key":"710_CR33","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/266730a0","volume":"266","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730\u2013732","journal-title":"Nature"},{"key":"710_CR34","first-page":"A40","volume":"11","author":"AM Redmond","year":"1997","unstructured":"Redmond AM, McNamara MG, Dredge K, Kelly JP, Leondard BE (1997) Onset of action of venlafaxine, citalopram, and desipramine in the OB rat model of depression. J Psychopharmacol 11:A40","journal-title":"J Psychopharmacol"},{"key":"710_CR35","unstructured":"Rosenzweig-Lipson S, Beyer C, Malberg J, Lin Q, Ashby CR, Graf R, Sung A, Grauer S, Logue S (2005) WAY-163909, a 5-HT2C selective agonist for the treatment of obesity, depression and schizophrenia: lack of tolerance. SFN Itinerary Viewer"},{"key":"710_CR36","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.brainres.2005.12.052","volume":"1073\u20131074","author":"S Rosenzweig-Lipson","year":"2006","unstructured":"Rosenzweig-Lipson S, Zhang J, Mazandarani H, Harrison BL, Sabb A, Sabalski J, Stack G, Welmaker G, Barrett JE, Dunlop J (2006) Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503. Brain Res 1073\u20131074:240\u2013251","journal-title":"Brain Res"},{"key":"710_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.pharmthera.2006.07.002","volume":"113","author":"S Rosenzweig-Lipson","year":"2007","unstructured":"Rosenzweig-Lipson S, Beyer CE, Hughes ZA, Khawaja X, Rajarao SJ, Malberg JE, Rahman Z, Ring RH, Schechter LE (2007) Differentiating antidepressants of the future: efficacy and safety. Pharmacol Ther 113:134\u2013153","journal-title":"Pharmacol Ther"},{"key":"710_CR38","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1016\/j.bmcl.2004.02.100","volume":"14","author":"AL Sabb","year":"2004","unstructured":"Sabb AL, Vogel RL, Welmaker G, Sabalski JE, Coupet J, Dunlop J, Rosenzweig-Lipson S, Harrison B (2004) Cycyloalkyl[b][1,4]benzodiazepinoindoles are agonists at the human 5-HT2C receptor. Bioorg Med Chem Lett 14:2603\u20132607","journal-title":"Bioorg Med Chem Lett"},{"key":"710_CR39","doi-asserted-by":"crossref","unstructured":"Sukoff Rizzo SJ, Schechter LE, Rosenzweig-Lipson S (2007) A novel approach for predicting antidepressant-induced sexual dysfunction in rats. Psychopharmacology, in press","DOI":"10.1007\/s00213-007-0924-7"},{"key":"710_CR40","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/sj.bjp.0703443","volume":"130","author":"SP Vickers","year":"2000","unstructured":"Vickers SP, Benwell KR, Porter RH, Bickerdike MJ, Kennett GA, Dourish CT (2000) Comparative effects of continuous infusion of mCPP, Ro 60\u20130175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats. Br J Pharmacol 130:1305\u20131314","journal-title":"Br J Pharmacol"},{"key":"710_CR41","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00213-002-1378-6","volume":"167","author":"SP Vickers","year":"2003","unstructured":"Vickers SP, Easton N, Webster LJ, Wyatt A, Bickerdike MJ, Dourish CT, Kennett GA (2003) Oral administration of the 5-HT2C receptor agonist, mCPP, reduces body weight gain in rats over 28\u00a0days as a result of maintained hypophagia. Psychopharmacology 167:274\u2013280","journal-title":"Psychopharmacology"},{"key":"710_CR42","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/S0960-894X(00)00400-5","volume":"10","author":"GS Welmaker","year":"2000","unstructured":"Welmaker GS, Nelson JA, Sabalski JE, Sabb AL, Potoski JR, Graziano D, Kagan K, Coupet J, Dunlop J, Mazandarani H, Rosenzweig-Lipson S, Sukoff S, Zhang Y (2000) Synthesis and 5-Hydroxytryptamine (5-HT) activity of 2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5-(6H)ones and 2,3,4,4a,5,6-hexahydro-1H-pyrazino[1,2-a]quinoxalines. Bioorg Med Chem Lett 10:1991\u20131994","journal-title":"Bioorg Med Chem Lett"},{"key":"710_CR43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF02244910","volume":"112","author":"A Woods","year":"1993","unstructured":"Woods A, Smith C, Szewczak M, Dunn RW, Cornfeldt M, Corbett R (1993) Selective serotonin reuptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive\u2013compulsive disorder. Psychopharmacology 112:195\u2013198","journal-title":"Psychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-007-0710-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-007-0710-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-007-0710-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-007-0710-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T19:10:21Z","timestamp":1736795421000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-007-0710-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,13]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["710"],"URL":"https:\/\/doi.org\/10.1007\/s00213-007-0710-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,13]]},"assertion":[{"value":"29 October 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}